Psychomotor slowing, negative symptoms and dopamine receptor availability—an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients
Andreas Heinz(Charité - Universitätsmedizin Berlin), Daniel R. Weinberger(Johns Hopkins University), Richard Coppola(United States Department of Health and Human Services), Douglas W. Jones(University of Massachusetts Chan Medical School), Julia G. Gorey, Michael B. Knable, Kan-Sam Lee(St. Elizabeths Hospital)
Cited by 129
Related Papers
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
|Brain|2009|962
Toward a new definition of mental health
|World Psychiatry|2015|924
Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts
|Psychophysiology|1993|687
Executive Subprocesses in Working Memory
|Archives of General Psychiatry|2003|585